These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 21324311

  • 1. Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies.
    Smith ER, Ford ML, Tomlinson LA, Weaving G, Rocks BF, Rajkumar C, Holt SG.
    Clin Chim Acta; 2011 May 12; 412(11-12):1008-11. PubMed ID: 21324311
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients.
    Fassbender WJ, Brandenburg V, Schmitz S, Sandig D, Simon SA, Windolf J, Stumpf UC.
    Clin Lab; 2009 May 12; 55(3-4):144-52. PubMed ID: 19462937
    [Abstract] [Full Text] [Related]

  • 3. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women.
    Burnett SM, Gunawardene SC, Bringhurst FR, Jüppner H, Lee H, Finkelstein JS.
    J Bone Miner Res; 2006 Aug 12; 21(8):1187-96. PubMed ID: 16869716
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.
    J Am Soc Nephrol; 2007 Sep 12; 18(9):2600-8. PubMed ID: 17656479
    [Abstract] [Full Text] [Related]

  • 5. Effect of a protease inhibitor on in vitro stability of intact parathyroid hormone.
    Anderson NR, Nicholas J, Holland MR, Gama R.
    Ann Clin Biochem; 2003 Mar 12; 40(Pt 2):188-90. PubMed ID: 12662411
    [Abstract] [Full Text] [Related]

  • 6. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H.
    N Engl J Med; 2003 Apr 24; 348(17):1656-63. PubMed ID: 12711740
    [Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M, Kalousová M, Kratochvílová M, Dusilová-Sulková S, Uhrová J, Bandúr S, Malbohan IM, Zima T, Tesar V.
    Kidney Blood Press Res; 2009 Apr 24; 32(4):276-83. PubMed ID: 19797911
    [Abstract] [Full Text] [Related]

  • 8. Determination of fibroblast growth factor 23.
    Heijboer AC, Levitus M, Vervloet MG, Lips P, ter Wee PM, Dijstelbloem HM, Blankenstein MA.
    Ann Clin Biochem; 2009 Jul 24; 46(Pt 4):338-40. PubMed ID: 19564163
    [Abstract] [Full Text] [Related]

  • 9. Novel regulators of phosphate homeostasis and bone metabolism.
    Jüppner H.
    Ther Apher Dial; 2007 Oct 24; 11 Suppl 1():S3-22. PubMed ID: 17976082
    [Abstract] [Full Text] [Related]

  • 10. The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays.
    Durham BH, Joseph F, Bailey LM, Fraser WD.
    Ann Clin Biochem; 2007 Sep 24; 44(Pt 5):463-6. PubMed ID: 17761032
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
    Young A, Hodsman AB, Boudville N, Geddes C, Gill J, Goltzman D, Jassal SV, Klarenbach S, Knoll G, Muirhead N, Prasad GV, Treleaven D, Garg AX, Donor Nephrectomy Outcomes Research (DONOR) Network.
    Am J Kidney Dis; 2012 Jun 24; 59(6):761-9. PubMed ID: 22093959
    [Abstract] [Full Text] [Related]

  • 13. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Jüppner H, Wolf M.
    J Am Soc Nephrol; 2005 Jul 24; 16(7):2205-15. PubMed ID: 15917335
    [Abstract] [Full Text] [Related]

  • 14. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephrol Dial Transplant; 2009 Sep 24; 24(9):2792-6. PubMed ID: 19395730
    [Abstract] [Full Text] [Related]

  • 15. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
    Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Uchida K, Nakanishi S, Kazama JJ, Gejyo F, Yamashita T, Fukagawa M.
    Am J Kidney Dis; 2004 Sep 24; 44(3):481-7. PubMed ID: 15332221
    [Abstract] [Full Text] [Related]

  • 16. FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.
    Seiler S, Reichart B, Roth D, Seibert E, Fliser D, Heine GH.
    Nephrol Dial Transplant; 2010 Dec 24; 25(12):3983-9. PubMed ID: 20525642
    [Abstract] [Full Text] [Related]

  • 17. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
    Damasiewicz MJ, Toussaint ND, Polkinghorne KR.
    Nephrology (Carlton); 2011 Mar 24; 16(3):261-8. PubMed ID: 21265930
    [Abstract] [Full Text] [Related]

  • 18. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia.
    Han SY, Hwang EA, Park SB, Kim HC, Kim HT.
    Transplant Proc; 2012 Apr 24; 44(3):657-60. PubMed ID: 22483462
    [Abstract] [Full Text] [Related]

  • 19. Reliability of plasma fibroblast growth factor 23 as risk biomarker in epidemiological studies measured over a four-month period.
    di Giuseppe R, Hirche F, Montonen J, Buijsse B, Dierkes J, Stangl GI, Boeing H, Weikert C.
    Ann Clin Biochem; 2012 Nov 24; 49(Pt 6):542-5. PubMed ID: 23002133
    [Abstract] [Full Text] [Related]

  • 20. Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia.
    Xia WB, Jiang Y, Li M, Xing XP, Wang O, Hu YY, Zhang HB, Liu HC, Meng XW, Zhou XY.
    Chin Med J (Engl); 2010 May 05; 123(9):1158-62. PubMed ID: 20529556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.